272 related articles for article (PubMed ID: 23597595)
1. Multiple mechanisms of action of pyridoxine in primary hyperoxaluria type 1.
Fargue S; Rumsby G; Danpure CJ
Biochim Biophys Acta; 2013 Oct; 1832(10):1776-83. PubMed ID: 23597595
[TBL] [Abstract][Full Text] [Related]
2. Effects of alanine:glyoxylate aminotransferase variants and pyridoxine sensitivity on oxalate metabolism in a cell-based cytotoxicity assay.
Fargue S; Knight J; Holmes RP; Rumsby G; Danpure CJ
Biochim Biophys Acta; 2016 Jun; 1862(6):1055-62. PubMed ID: 26854734
[TBL] [Abstract][Full Text] [Related]
3. Pyridoxamine and pyridoxal are more effective than pyridoxine in rescuing folding-defective variants of human alanine:glyoxylate aminotransferase causing primary hyperoxaluria type I.
Oppici E; Fargue S; Reid ES; Mills PB; Clayton PT; Danpure CJ; Cellini B
Hum Mol Genet; 2015 Oct; 24(19):5500-11. PubMed ID: 26199318
[TBL] [Abstract][Full Text] [Related]
4. Four of the most common mutations in primary hyperoxaluria type 1 unmask the cryptic mitochondrial targeting sequence of alanine:glyoxylate aminotransferase encoded by the polymorphic minor allele.
Fargue S; Lewin J; Rumsby G; Danpure CJ
J Biol Chem; 2013 Jan; 288(4):2475-84. PubMed ID: 23229545
[TBL] [Abstract][Full Text] [Related]
5. Gly161 mutations associated with Primary Hyperoxaluria Type I induce the cytosolic aggregation and the intracellular degradation of the apo-form of alanine:glyoxylate aminotransferase.
Oppici E; Roncador A; Montioli R; Bianconi S; Cellini B
Biochim Biophys Acta; 2013 Dec; 1832(12):2277-88. PubMed ID: 24055001
[TBL] [Abstract][Full Text] [Related]
6. Correlation between the molecular effects of mutations at the dimer interface of alanine-glyoxylate aminotransferase leading to primary hyperoxaluria type I and the cellular response to vitamin B
Dindo M; Oppici E; Dell'Orco D; Montone R; Cellini B
J Inherit Metab Dis; 2018 Mar; 41(2):263-275. PubMed ID: 29110180
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic rescue of an enzyme-trafficking defect in primary hyperoxaluria 1.
Miyata N; Steffen J; Johnson ME; Fargue S; Danpure CJ; Koehler CM
Proc Natl Acad Sci U S A; 2014 Oct; 111(40):14406-11. PubMed ID: 25237136
[TBL] [Abstract][Full Text] [Related]
8. Misfolding caused by the pathogenic mutation G47R on the minor allele of alanine:glyoxylate aminotransferase and chaperoning activity of pyridoxine.
Montioli R; Oppici E; Dindo M; Roncador A; Gotte G; Cellini B; Borri Voltattorni C
Biochim Biophys Acta; 2015 Oct; 1854(10 Pt A):1280-9. PubMed ID: 26149463
[TBL] [Abstract][Full Text] [Related]
9. Cycloserine enantiomers are reversible inhibitors of human alanine:glyoxylate aminotransferase: implications for Primary Hyperoxaluria type 1.
Dindo M; Grottelli S; Annunziato G; Giardina G; Pieroni M; Pampalone G; Faccini A; Cutruzzolà F; Laurino P; Costantino G; Cellini B
Biochem J; 2019 Dec; 476(24):3751-3768. PubMed ID: 31794008
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of alanine:glyoxylate aminotransferase 1 dimerization is a prerequisite for its peroxisome-to-mitochondrion mistargeting in primary hyperoxaluria type 1.
Leiper JM; Oatey PB; Danpure CJ
J Cell Biol; 1996 Nov; 135(4):939-51. PubMed ID: 8922378
[TBL] [Abstract][Full Text] [Related]
11. Reconstruction of human hepatocyte glyoxylate metabolic pathways in stably transformed Chinese-hamster ovary cells.
Behnam JT; Williams EL; Brink S; Rumsby G; Danpure CJ
Biochem J; 2006 Mar; 394(Pt 2):409-16. PubMed ID: 16309382
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of human alanine:glyoxylate aminotransferase in Escherichia coli: renaturation from guanidine-HCl and affinity for pyridoxal phosphate co-factor.
Coulter-Mackie MB; Lian Q; Wong SG
Protein Expr Purif; 2005 May; 41(1):18-26. PubMed ID: 15802217
[TBL] [Abstract][Full Text] [Related]
13. Pyridoxine effect in type I primary hyperoxaluria is associated with the most common mutant allele.
Monico CG; Rossetti S; Olson JB; Milliner DS
Kidney Int; 2005 May; 67(5):1704-9. PubMed ID: 15840016
[TBL] [Abstract][Full Text] [Related]
14. Further studies on the activity and subcellular distribution of alanine:glyoxylate aminotransferase in the livers of patients with primary hyperoxaluria type 1.
Danpure CJ; Jennings PR
Clin Sci (Lond); 1988 Sep; 75(3):315-22. PubMed ID: 3416563
[TBL] [Abstract][Full Text] [Related]
15. Biochemical and cellular effects of a novel missense mutation of the AGXT gene associated with Primary Hyperoxaluria Type 1.
Gatticchi L; Dindo M; Pampalone G; Conter C; Cellini B; Takayama T
Biochem Biophys Res Commun; 2023 Feb; 645():118-123. PubMed ID: 36682331
[TBL] [Abstract][Full Text] [Related]
16. [From gene to disease; primary hyperoxaluria type I caused by mutations in the AGXT gene].
van Woerden CS; Groothof JW; Wanders RJ; Waterham HR; Wijburg FR
Ned Tijdschr Geneeskd; 2006 Jul; 150(30):1669-72. PubMed ID: 16922352
[TBL] [Abstract][Full Text] [Related]
17. Molecular Insight into the Synergism between the Minor Allele of Human Liver Peroxisomal Alanine:Glyoxylate Aminotransferase and the F152I Mutation.
Cellini B; Montioli R; Paiardini A; Lorenzetto A; Voltattorni CB
J Biol Chem; 2009 Mar; 284(13):8349-58. PubMed ID: 19155213
[TBL] [Abstract][Full Text] [Related]
18. Mammalian alanine/glyoxylate aminotransferase 1 is imported into peroxisomes via the PTS1 translocation pathway. Increased degeneracy and context specificity of the mammalian PTS1 motif and implications for the peroxisome-to-mitochondrion mistargeting of AGT in primary hyperoxaluria type 1.
Motley A; Lumb MJ; Oatey PB; Jennings PR; De Zoysa PA; Wanders RJ; Tabak HF; Danpure CJ
J Cell Biol; 1995 Oct; 131(1):95-109. PubMed ID: 7559790
[TBL] [Abstract][Full Text] [Related]
19. Primary hyperoxaluria type 1: AGT mistargeting highlights the fundamental differences between the peroxisomal and mitochondrial protein import pathways.
Danpure CJ
Biochim Biophys Acta; 2006 Dec; 1763(12):1776-84. PubMed ID: 17027096
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
